PPI plus aspirin for secondary cardiovascular disease prevention

被引：0
作者：
Ng, Siew C. [1 ]
Chan, Francis K. L. [1 ]
机构：
[1] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2011年 / 8卷 / 10期
关键词：
LOW-DOSE ASPIRIN; COST-EFFECTIVENESS; LONG-TERM; THERAPY;
D O I：
10.1038/nrgastro.2011.164
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Aspirin is widely used for cardiovascular disease prevention, but is associated with adverse gastrointestinal effects, which reduce the likelihood of treatment compliance. A new study shows that PPI co-therapy reduces gastrointestinal and cardiovascular events, and is cost-effective at generic price for treating patients who take aspirin for secondary cardiovascular disease prevention.
引用
收藏
页码：543 / 545
页数：4
相关论文
共 10 条
  • [1] ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents
    Bhatt, Deepak L.
    Scheiman, James
    Abraham, Neena S.
    Antman, Elliott M.
    Chan, Francis K. L.
    Furberg, Curt D.
    Johnson, David A.
    Mahaffey, Kenneth W.
    Quigley, Eamonn M.
    [J]. CIRCULATION, 2008, 118 (18) : 1894 - 1909
  • [2] Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding
    Chan, FKL
    Ching, JYL
    Hung, LCT
    Wong, VWS
    Leung, VKS
    Kung, NNS
    Hui, AJ
    Wu, JCY
    Leung, WK
    Lee, VWY
    Lee, KKC
    Lee, YT
    Lau, JYW
    To, KF
    Chan, HLY
    Chung, SCS
    Sung, JJY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (03) : 238 - 244
  • [3] Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1
  • [4] Cost-Utility of Aspirin and Proton Pump Inhibitors for Primary Prevention
    Earnshaw, Stephanie R.
    Scheiman, James
    Fendrick, A. Mark
    McDade, Cheryl
    Pignone, Michael
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (03) : 218 - 225
  • [5] Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use
    Lai, KC
    Lam, SK
    Chu, KM
    Wong, BCY
    Hui, WM
    Hu, WHC
    Lau, GKK
    Wong, WM
    Yuen, MF
    Chan, AOO
    Lai, CL
    Wong, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26) : 2033 - 2038
  • [6] Predictors of Early Discontinuation of Evidence-Based Medicine After Acute Coronary Syndrome
    Melloni, Chiara
    Alexander, Karen P.
    Ou, Fang-Shu
    LaPointe, Nancy M. Allen
    Roe, Matthew T.
    Newby, L. Kristin
    Baloch, Khaula
    Ho, P. Michael
    Rumsfeld, John S.
    Peterson, Eric D.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (02) : 175 - 181
  • [7] Does PPI therapy predispose to Clostridium difficile infection?
    Pant, Chaitanya
    Madonia, Phillip
    Minocha, Anil
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (09) : 555 - 557
  • [8] Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention
    Saini, S. D.
    Fendrick, A. M.
    Scheiman, J. M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (02) : 243 - 251
  • [9] Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention
    Saini, Sameer D.
    Schoenfeld, Philip
    Fendrick, A. Mark
    Scheiman, James
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) : 1684 - 1690
  • [10] Continuation of Low-Dose Aspirin Therapy in Peptic Ulcer Bleeding A Randomized Trial
    Sung, Joseph J. Y.
    Lau, James Y. W.
    Ching, Jessica Y. L.
    Wu, Justin C. Y.
    Lee, Yuk T.
    Chiu, Philip W. Y.
    Leung, Vincent K. S.
    Wong, Vincent W. S.
    Chan, Francis K. L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2010, 152 (01) : 1 - W1
1